| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PPT2-EGFL8 readthrough (NMD candidate) | 0.792 | 0.462 |
|
disease | 0.100 | None | 1.000 | 3 | 6 | 2007 | 2011 | |||||||||
|
lymphocyte antigen 6 family member G6D | 0.805 | 0.385 | 3.3E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 2 | 2007 | 2011 | ||||||||
|
serine/threonine kinase 19 | 0.691 | 0.500 | 6.7E-09 |
|
disease | 0.100 | None | 1.000 | 3 | 5 | 2007 | 2011 | ||||||||
|
ring finger protein 5 | 0.716 | 0.538 | 3.7E-05 |
|
disease | 0.100 | None | 1.000 | 3 | 7 | 2007 | 2011 | ||||||||
|
C2 antisense RNA 1 | 0.821 | 0.192 |
|
disease | 0.100 | None | 1.000 | 3 | 5 | 2007 | 2011 | |||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 10 | 2007 | 2011 | |||||||||
|
HLA complex group 27 | 0.805 | 0.346 | 2.3E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 4 | 2007 | 2011 | ||||||||
|
tripartite motif containing 26 | 0.705 | 0.577 | 0.18 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2007 | 2009 | ||||||||
|
valyl-tRNA synthetase 2, mitochondrial | 0.666 | 0.577 | 5.8E-17 |
|
disease | 0.100 | None | 1.000 | 2 | 4 | 2007 | 2009 | ||||||||
|
lymphocyte antigen 6 family member G6F | 0.861 | 0.308 | 9.6E-07 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2007 | 2009 | ||||||||
|
discoidin domain receptor tyrosine kinase 1 | 0.497 | 0.808 | 4.6E-06 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2007 | 2009 | ||||||||
|
coiled-coil alpha-helical rod protein 1 | 0.505 | 0.808 | 1.0E-16 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2009 | ||||||||
|
tripartite motif containing 40 | 0.890 | 0.192 | 6.2E-11 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2007 | 2009 | ||||||||
|
VPS52 subunit of GARP complex | 0.780 | 0.231 | 3.9E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2009 | ||||||||
|
PBX homeobox 2 | 0.686 | 0.462 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 5 | 2007 | 2011 | ||||||||
|
G protein nucleolar 1 (putative) | 0.805 | 0.423 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2007 | 2009 | ||||||||
|
HLA complex group 17 | 0.769 | 0.346 |
|
disease | 0.100 | None | 1.000 | 2 | 6 | 2007 | 2009 | |||||||||
|
downregulated RNA in cancer, inhibitor of cell invasion and migration | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2019 | |||||||||
|
ATP binding cassette subfamily F member 1 | 0.674 | 0.538 | 1.3E-09 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2007 | 2009 | ||||||||
|
mucin like 3 | 0.691 | 0.731 | 1.2E-05 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2007 | 2009 | ||||||||
|
HLA complex group 22 (gene/pseudogene) | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2009 | |||||||||
|
phosphatase and actin regulator 3 | 0.861 | 0.231 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 2649 | 0.792 | 0.308 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2019 | |||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2009 | 2019 | ||||||||
|
zinc ribbon domain containing 1 antisense, pseudogene | 0.691 | 0.538 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2009 |